Study: Early advanced therapy significantly improves Crohn's disease outcomes

A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve outcomes, including by reducing the number of people requiring urgent abdominal surgery for treatment of their disease by ten-fold.

Related Keywords

United Kingdom ,Peterborough ,Cambridge ,Cambridgeshire ,London ,City Of ,Toby Moore ,Ruth Wakeman ,University Of Cambridge ,Cambridge Biomedical Research Centre ,Department Of Medicine ,Predictimmune Ltd ,Care Research ,Clinical Research Network ,National Institute For Health ,Cambridge University Hospitals ,Wellcome ,National Institute ,Lancet Gastroenterology ,Miles Parkes ,Chief Investigator ,Biomedical Research ,Colitis United Kingdom ,Year Six ,Royal Free Hospital ,Biomarker ,Flood ,Clinical Trial ,Crohn 39s Disease ,Diarrhoea ,Diet ,Digestive System ,Drugs ,Fatigue ,Wood ,Astroenterology ,Enetic ,Hepatology ,Hospital ,Immune System ,Immunosuppression ,Inflammation ,Infliximab ,Medicine ,Necrosis ,Rain ,Protein ,Research ,Skin ,Stomach ,Stomach Pain ,Stress ,Surgery ,Top Down ,Weight Loss ,